| Financial Year |
September 30 2019 |
| Monetary Funds |
67,979,654.09 |
| Held-for-trading Financial Assets |
204,838,709.68 |
| Notes Receivable |
2,643,645.96 |
| Accounts Receivable |
462,841,924.97 |
| Advances to Suppliers |
17,987,916.54 |
| Other Receivables |
71,669,490.30 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,507,361,123.87 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
218,110,336.94 |
| Total Current Assets |
3,553,432,802.35 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
123,119,976.23 |
| Investment Properties |
2,398,775,900.00 |
| Fixed Assetes |
73,028,714.45 |
| Under-construction Projects |
105,982,631.20 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
372,444,585.06 |
| R&D expenses |
-- |
| Goodwill |
198,817,281.71 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
9,093,320.78 |
| Other Non-Current Assets |
2,050,517,235.06 |
| Sub-Total of Non-Current Assets |
5,506,619,507.55 |
| Total Assets |
9,060,052,309.90 |
| Short-Term Loans |
1,687,996,267.38 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
308,571,316.04 |
| Accounts Received In Advance |
167,534,305.85 |
| Employee Compensation Payable |
14,238,034.51 |
| Taxes Payable |
1,031,537,650.50 |
| Interest Payable |
376,367,457.76 |
| Dividend Payable |
50,761,188.60 |
| Other payables |
537,469,004.92 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,034,802,845.60 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
6,782,149,424.80 |
| Long-term Loans |
431,250,000.00 |
| Bonds Payable |
2,117,768,644.32 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
3,630,440,885.88 |
| Deferred Income Tax Liabilities |
193,175,262.92 |
| Other Non-Current Liabilities |
758,550,000.00 |
| Sub-Total of Non-Current Liabilities |
7,131,184,793.12 |
| Total Liabilities |
13,913,334,217.92 |
| Paid-In Capital(Or Share Stock) |
1,424,253,600.00 |
| Capital Surplus |
564,419,199.09 |
| Surplus Reserve |
108,434,796.33 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-6,923,269,672.95 |
| Minority Stockholder's Interest |
-33,086,465.88 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-4,820,195,442.14 |
| Owner's Equity（Stockholder's Equity） |
-4,853,281,908.02 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,060,052,309.90 |
